miR-126 suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6569-6572

  Yu, Qing ^a,b   Liu, Shan Ling ^a,b   Wang, He ^a,b   Shi, Gang ^a   Yang, Pei ^a   Chen, Xin Lian ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Bleomycin; Cervical cancer; Drug sensitivity; MiR 126

Indexed keywords

EID: 84892468489     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6569     Document Type: Article

References (18)

1. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
2. Feng R, Chen X, Yu Y, et al (2010). miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett, 298, 50-63.
3. Hamada S, Satoh K, Fujibuchi W, et al (2011). MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res, 10, 3-10.
4. Harris TA, Yamakuchi M, Ferlito M, et al (2008). MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A, 105, 1516-21.
5. Hong L, Piao Y, Han Y, et al (2005). Zinc ribbon domaincontaining 1(ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther, 4, 1936-42.
6. Hou J, Lin L, Zhou W, et al (2011). Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR- 199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 19, 232-43.
7. Hu X, Schwarz JK, Lewis JS Jr, et al (2010). A microRNA expression signature for cervical cancer prognosis. Cancer Res, 70, 1441-8.
8. Kuhnert F, Mancuso MR, Hampton J, et al (2008). Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development, 135, 3989-93.
9. Li JH, Xiao X, Zhang YN, et al (2011). MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol, 120, 145-51.
10. Musiyenko A, Bitko V, Barik S (2008). Ectopic expression of miR-126, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. Mol Med (Berl), 86, 313-22.
11. Oglesby IK, Bray IM, Chotirmall SH, et al (2010). miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol, 184, 1702-9.
12. van Solingen C, de Boerl HC, Bijkerk R, et al (2011). MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-11/Lin2 progenitor cells in ischaemia. Cardiovasc Res, 92, 449-55.
13. Wang X, Tang S, Le SY, et al (2008). Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One, 3, e2557.
14. Wang S, Aurora AB, Johnson BA, et al (2008b). The endothelialspecific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell, 15, 261-71.
15. Yang Z, Chen S, Luan X, et al (2009). MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life, 61, 1075-82.
16. Zampetaki A, Kiechl S, Drozdov I, et al (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res, 107, 810-7.
17. Zhu N, Zhang D, Xie H, et al (2011). Endothelial-specific intronderived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem, 351, 157-64.
18. Zhu X, Li H, Long L, et al (2012). miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. Acta Biochim Biophys Sin, 44, 519-26.